CareLit Fachartikel
Neutrophil-lymphocyte ratio: an independent predictor of the herpes zoster risk in rheumatoid arthritis patients treated with tofacitinib
Pengcheng Liu, Min Zhang, Yueqin Zhang, Shujiao Yu, Rui Wu · Aktuelle Rheumatologie · 2025 · Heft 02 · S. 134-140
Dokument
937677
CareLit-ID
Jahr
2025
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
AbstractTo investigate the role of the neutrophil-lymphocyte ratio (NLR) in the risk of developing herpes zoster (HZ) in patients with rheumatoid arthritis (RA) receiving tofacitinib. This was a prospective observational study recruiting patients who were diagnosed with RA and treated with tofacitinib. Patients with previous herpes zoster infections were excluded from this study. All patients were assessed for HZ every 1–3 months and were followed up for 12 months. Univariate and multivariate logistic regression analyses were used to assess the relationship between NLR and HZ. A cutoff value of NLR was determine…
Schlagworte
herpes zoster
rheumatoid arthritis
tofacitinib
biomarker
neutrophil-lymphocyte ratio
rheumatoide Arthritis
Neutrophil-Lymphozyten-Verhältnis
Aktuelle Rheumatologie
